{"id":"https://openalex.org/W3010245832","doi":"https://doi.org/10.1016/j.jphs.2020.02.010","title":"Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice","display_name":"Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice","publication_year":2020,"publication_date":"2020-03-02","ids":{"openalex":"https://openalex.org/W3010245832","doi":"https://doi.org/10.1016/j.jphs.2020.02.010","mag":"3010245832","pmid":"https://pubmed.ncbi.nlm.nih.gov/32199747"},"language":"en","primary_location":{"id":"doi:10.1016/j.jphs.2020.02.010","doi":"https://doi.org/10.1016/j.jphs.2020.02.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2020.02.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861320300268/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S1347861320300268/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113870243","display_name":"Shunji Nishide","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shunji Nishide","raw_affiliation_strings":["Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan; Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan; Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]},{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]},{"raw_affiliation_string":"Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001730366","display_name":"Junji Uchida","orcid":"https://orcid.org/0000-0002-0113-8058","observed_orcids":["https://orcid.org/0000-0002-0113-8058","https://orcid.org/0000-0003-3629-6686"]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junji Uchida","raw_affiliation_strings":["Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102070288","display_name":"Shinji Matsunaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shinji Matsunaga","raw_affiliation_strings":["Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan. Electronic address: matsunaga.shinji@med.osaka-cu.ac.jp","Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan. Electronic address: matsunaga.shinji@med.osaka-cu.ac.jp","institution_ids":["https://openalex.org/I317356780"]},{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044708206","display_name":"Kentaro Tokudome","orcid":"https://orcid.org/0000-0001-8478-5885","observed_orcids":["https://orcid.org/0000-0001-8478-5885"]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kentaro Tokudome","raw_affiliation_strings":["Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059281162","display_name":"Takehiro Yamaguchi","orcid":"https://orcid.org/0000-0002-5965-6499","observed_orcids":["https://orcid.org/0000-0002-5965-6499"]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takehiro Yamaguchi","raw_affiliation_strings":["Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046398349","display_name":"Kazuya Kabei","orcid":"https://orcid.org/0000-0001-9473-6008","observed_orcids":["https://orcid.org/0000-0001-9473-6008"]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuya Kabei","raw_affiliation_strings":["Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045691862","display_name":"Taiki Moriya","orcid":"https://orcid.org/0000-0001-8638-7733","observed_orcids":["https://orcid.org/0000-0001-8638-7733"]},"institutions":[{"id":"https://openalex.org/I167598709","display_name":"Osaka Ohtani University","ror":"https://ror.org/01jtn9895","country_code":"JP","type":"education","lineage":["https://openalex.org/I167598709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taiki Moriya","raw_affiliation_strings":["Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University, Osaka 584-8540, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University, Osaka 584-8540, Japan","institution_ids":["https://openalex.org/I167598709"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Katsuyuki Miura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuyuki Miura","raw_affiliation_strings":["Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102879170","display_name":"Tatsuya Nakatani","orcid":"https://orcid.org/0000-0003-4949-5123","observed_orcids":["https://orcid.org/0000-0003-4949-5123","https://orcid.org/0009-0008-5703-016X"]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuya Nakatani","raw_affiliation_strings":["Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112308237","display_name":"Shuhei Tomita","orcid":"https://orcid.org/0000-0003-3632-2485","observed_orcids":["https://orcid.org/0000-0003-3632-2485"]},"institutions":[{"id":"https://openalex.org/I317356780","display_name":"Osaka City University","ror":"https://ror.org/02skfsw40","country_code":"JP","type":"education","lineage":["https://openalex.org/I317356780","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shuhei Tomita","raw_affiliation_strings":["Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan. Electronic address: tomita.shuhei@med.osaka-cu.ac.jp","Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan. Electronic address: tomita.shuhei@med.osaka-cu.ac.jp","institution_ids":["https://openalex.org/I317356780"]},{"raw_affiliation_string":"Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan","institution_ids":["https://openalex.org/I317356780"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5102070288","https://openalex.org/A5112308237"],"corresponding_institution_ids":["https://openalex.org/I317356780"],"apc_list":{"value":1000,"currency":"USD","value_usd":1000},"apc_paid":{"value":1000,"currency":"USD","value_usd":1000},"fwci":1.0676,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.72978801,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"143","issue":"2","first_page":"122","last_page":"126"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.05820000171661377,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prolyl-hydroxylase-inhibitors","display_name":"prolyl hydroxylase inhibitors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.8199999928474426},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8980000019073486},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.8220000267028809},{"id":"https://openalex.org/keywords/tumor-perfusion","display_name":"tumor perfusion","score":0.7210000157356262},{"id":"https://openalex.org/keywords/reoxygenation","display_name":"reoxygenation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/roxadustat","display_name":"roxadustat","score":0.9259999990463257},{"id":"https://openalex.org/keywords/daprodustat","display_name":"daprodustat","score":0.921999990940094},{"id":"https://openalex.org/keywords/molidustat","display_name":"molidustat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vadadustat","display_name":"vadadustat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.6610000133514404},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor","display_name":"hypoxia-inducible factor","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C2779081379","wikidata":"https://www.wikidata.org/wiki/Q7852677","display_name":"Tumor hypoxia","level":3,"score":0.6554374694824219},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5996373891830444},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.5852543711662292},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5292567610740662},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4676826596260071},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44795289635658264},{"id":"https://openalex.org/C146957229","wikidata":"https://www.wikidata.org/wiki/Q1266915","display_name":"Perfusion","level":2,"score":0.44588953256607056},{"id":"https://openalex.org/C2777663904","wikidata":"https://www.wikidata.org/wiki/Q988343","display_name":"Blood vessel","level":2,"score":0.4448021650314331},{"id":"https://openalex.org/C158846371","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Blood flow","level":2,"score":0.4291744530200958},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.3996555805206299},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3693966269493103},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3503206670284271},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3442686200141907},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25332432985305786},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.09233292937278748},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010101","descriptor_name":"Oxygen Consumption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010848","descriptor_name":"Picolinic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018827","descriptor_name":"Carcinoma, Lewis Lung","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D018827","descriptor_name":"Carcinoma, Lewis Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D064800","descriptor_name":"Prolyl-Hydroxylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jphs.2020.02.010","doi":"https://doi.org/10.1016/j.jphs.2020.02.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2020.02.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861320300268/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:32199747","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32199747","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological sciences","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:710a0948a85942fbbe28c400d0dc2919","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/710a0948a85942fbbe28c400d0dc2919","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacological Sciences, Vol 143, Iss 2, Pp 122-126 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jphs.2020.02.010","doi":"https://doi.org/10.1016/j.jphs.2020.02.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2020.02.010","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861320300268/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1996258685","display_name":"Elucidation of anti-tumor mechanisms based on innate immune activation by PHD inhibitors and exploration of therapeutic targets","funder_award_id":"20K07072","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G3364597796","display_name":"Elucidation of Molecular Mechanism of Mycobacterial Latency via Mycobacterial Membrane Vesicles","funder_award_id":"19K16651","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G4504294231","display_name":"Enhancement of anti-tumor immunity by the promortion of  the tumor infiltration of CD103+ dendritic cells","funder_award_id":"18K14598","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G8965692815","display_name":"Angiogenesis in renal fibrosis","funder_award_id":"17K08958","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3010245832.pdf","grobid_xml":"https://content.openalex.org/works/W3010245832.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1992112921","https://openalex.org/W2022540958","https://openalex.org/W2087377825","https://openalex.org/W2268447664","https://openalex.org/W2603878954","https://openalex.org/W2756198750","https://openalex.org/W2833377694","https://openalex.org/W2970039515","https://openalex.org/W2991750859","https://openalex.org/W6770462155"],"related_works":["https://openalex.org/W3084173479","https://openalex.org/W3138628962","https://openalex.org/W7219157622","https://openalex.org/W4226040791","https://openalex.org/W3166230976","https://openalex.org/W2136023563","https://openalex.org/W1991201872","https://openalex.org/W2024740314","https://openalex.org/W4313198945","https://openalex.org/W6946098693"],"abstract_inverted_index":{"Tumor":[0],"blood":[1,7,39,81],"vessels":[2,82],"have":[3],"leaky":[4],"and":[5,14,45,58,65,83,87],"low":[6,15],"flow":[8],"properties,":[9],"which":[10],"lead":[11],"to":[12],"hypoxia":[13],"nutrient":[16],"levels":[17],"in":[18,62,95],"the":[19,25,32,47,85],"tumor":[20,26,38,42,48,80],"tissue":[21,43],"area":[22],"known":[23],"as":[24],"microenvironment":[27],"(TME).":[28],"We":[29],"reported":[30],"that":[31,76],"prolyl-hydroxylase":[33],"(PHD)":[34],"inhibitor":[35],"Roxadustat":[36],"normalized":[37],"vessels,":[40],"improved":[41,84],"perfusion,":[44],"re-oxygenated":[46],"tissue.":[49],"Recently,":[50],"several":[51],"PHD":[52,77],"inhibitors":[53,78],"including":[54],"Roxadustat,":[55],"Daprodustat,":[56],"Molidustat,":[57],"Vadadustat,":[59],"were":[60],"evaluated":[61],"clinical":[63],"trials":[64],"approved":[66],"for":[67],"treating":[68],"renal":[69],"anemia.":[70],"In":[71],"this":[72],"study,":[73],"we":[74],"showed":[75],"reconstituted":[79],"TME,":[86],"some":[88],"agents":[89],"exhibited":[90],"differential":[91],"effects":[92],"on":[93],"tumors":[94],"a":[96],"mouse":[97],"model.":[98]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2020-03-13T00:00:00"}